BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/20/2014 9:09:00 AM | Browse: 1032 | Download: 1244
 |
Received |
|
2013-11-30 15:26 |
 |
Peer-Review Started |
|
2013-11-30 20:08 |
 |
To Make the First Decision |
|
2014-03-12 16:56 |
 |
Return for Revision |
|
2014-03-20 20:13 |
 |
Revised |
|
2014-04-17 19:11 |
 |
Second Decision |
|
2014-09-17 13:54 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-09-17 14:18 |
 |
Articles in Press |
|
2014-09-17 14:18 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-10-13 12:00 |
 |
Publish the Manuscript Online |
|
2014-10-20 09:08 |
Category |
Surgery |
Manuscript Type |
Minireviews |
Article Title |
Peritoneal metastases of colorectal origin treated by cytoreduction and HIPEC: An overview
|
Manuscript Source |
Invited Manuscript |
All Author List |
Alvaro Arjona-Sánchez, Francisco Javier Medina-Fernández, Francisco Cristobal Muñoz-Casares, Angela Casado-Adam, Juan Manuel Sánchez-Hidalgo and Sebastián Rufián-Peña |
Funding Agency and Grant Number |
|
Corresponding Author |
Dr. Alvaro Arjona-Sánchez, Unit of Oncological and Pancreatic Surgery, Department of General and Digestive Surgery, University Hospital Reina Sofia, Avda.Menéndez Pidal s/n, 14004 Córdoba, Spain. alvaroarjona@hotmail.com |
Key Words |
Carcinomatosis peritoneal; Colon cancer; Intraperitoneal chemotherapy; Cytoreduction; Peritonectomy |
Core Tip |
The carcinomatosis peritoneal from colon origin has turned from a terminal condition to a curative scenery. The cytoreduction and peritonectomy procedures with hyperthermic intraperitoneal chemotherapy have achieved 50% in 5 years overall survival, with a low morbidity that is not higher than other major surgical procedures. |
Publish Date |
2014-10-20 09:08 |
Citation |
Arjona-Sánchez A, Medina-Fernández FJ, Muñoz-Casares FC, Casado-Adam A, Sánchez-Hidalgo JM, Rufián-Peña S. Peritoneal metastases of colorectal origin treated by cytoreduction and HIPEC: An overview. World J Gastrointest Oncol 2014; 6(10): 407-412 |
URL |
http://www.wjgnet.com/1948-5204/full/v6/i10/407.htm |
DOI |
http://dx.doi.org/10.4251/wjgo.v6.i10.407 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345